Invesco’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $291M | Buy |
|
|||||
2025
Q1 | $310M | Buy |
|
|||||
2024
Q4 | $326M | Buy |
|
|||||
2024
Q3 | $316M | Buy |
|
|||||
2024
Q2 | $299M | Sell |
|
|||||
2024
Q1 | $360M | Sell |
|
|||||
2023
Q4 | $470M | Buy |
|
|||||
2023
Q3 | $304M | Buy |
|
|||||
2023
Q2 | $283M | Sell |
|
|||||
2023
Q1 | $285M | Buy |
|
|||||
2022
Q4 | $255M | Sell |
|
|||||
2022
Q3 | $259M | Buy |
|
|||||
2022
Q2 | $195M | Buy |
|
|||||
2022
Q1 | $201M | Sell |
|
|||||
2021
Q4 | $271M | Buy |
|
|||||
2021
Q3 | $280M | Sell |
|
|||||
2021
Q2 | $361M | Buy |
|
|||||
2021
Q1 | $289M | Buy |
|
|||||
2020
Q4 | $206M | Sell |
|
|||||
2020
Q3 | $256M | Sell |
|
|||||
2020
Q2 | $243M | Sell |
|
|||||
2020
Q1 | $299M | Sell |
|
|||||
2019
Q4 | $325M | Sell |
|
|||||
2019
Q3 | $668M | Sell |
|
|||||
2019
Q2 | $700M | Sell |
|
|||||
2019
Q1 | $764M | Buy |
|
|||||
2018
Q4 | $941M | Sell |
|
|||||
2018
Q3 | $1.28B | Sell |
|
|||||
2018
Q2 | $1.12B | Buy |
|
|||||
2018
Q1 | $974M | Buy |
|
|||||
2017
Q4 | $1.1B | Buy |
|
|||||
2017
Q3 | $1.06B | Sell |
|
|||||
2017
Q2 | $934M | Sell |
|
|||||
2017
Q1 | $1.13B | Sell |
|
|||||
2016
Q4 | $1.2B | Buy |
|
|||||
2016
Q3 | $1.32B | Buy |
|
|||||
2016
Q2 | $991M | Buy |
|
|||||
2016
Q1 | $941M | Buy |
|
|||||
2015
Q4 | $1B | Sell |
|
|||||
2015
Q3 | $1B | Buy |
|
|||||
2015
Q2 | $1.33B | Sell |
|
|||||
2015
Q1 | $1.5B | Buy |
|
|||||
2014
Q4 | $1.13B | Sell |
|
|||||
2014
Q3 | $1.18B | Sell |
|
|||||
2014
Q2 | $1.21B | Sell |
|
|||||
2014
Q1 | $1.24B | Buy |
|
|||||
2013
Q4 | $1.03B | Sell |
|
|||||
2013
Q3 | $903M | Buy |
|
|||||
2013
Q2 | $704M | Buy |
|